Tobacco smoke as a risk factor for meningococcal disease

Pediatric Infectious Disease Journal

Volumn 16, Issue 10, 1997, Pages 979-983

  Fischer, Marc ^a   Hedberg, Katrina ^b   Cardosi, Paul ^b   Plikaytis, Brian D ^a   Hoesly, Frederick C ^b   Steingart, Karen R ^c   Bell, Thomas A ^d   Fleming, David W ^b   Wenger, Jay D ^a   Perkins, Bradley A ^a,e  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b OREGON PUBLIC HEALTH DIVISION   (United States)

^c Southwest Washington Health District   (United States)

^d Cowlitz County Health Department ^*  (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Epidemielogy; Neisseria meningitidis; Risk factors; Smoking

Indexed keywords

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ARTICLE; CHILD; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PRIORITY JOURNAL; SMOKING; TREATMENT FAILURE; UNITED STATES;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DATA COLLECTION; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; TOBACCO SMOKE POLLUTION;

EID: 0030763468     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199710000-00015     Document Type: Article

References (34)

1. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR 1993;42(SS-2):21-30.
2. Centers for Disease Control and Prevention. Control and prevention of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR 1997;46:1-10.
3. Ross SC, Densen P. Complement deficiency states and infection epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984;63:243-73.
4. Franke EL, Neu HC. Postsplenectomy infection. Surg Clin North Am 1981;61:135-55.
5. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski ER, Palmer SR. Influenza A and meningococcal disease. Lancet 1991;338:554-7.
6. Moore PS, Hierholzer J, DeWitt W, et al. Respiratory viruses and Mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990;264:1271-5.
7. Krasinski K, Nelson JD, Butler S, Luby JP, Kusimiesz H. Possible association of Mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol 1987; 125:499-508.
8. Young LS, LaForce FM, Head JJ, Feeley JC, Bennett JV. A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 1972;287:5-9.
9. Haneberg B, Tonjum T, Rodahl K, Gedde-Dahl TW. Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, stressful events, physical fitness and general symptoms of ill health. NIPH Ann 1983;6: 169-73.
10. Stuart JM, Cartwright KA, Dawson JA, Richard J, Noah ND. Risk factors for meningococcal disease: a case control study in south west England. Community Med 1988;10:139-46.
11. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect 1994;112:315-28.
12. Zeitz P, Jafari H, Kioski C, et al. A cluster of Neisseria meningitidis serogroup C disease in Phoenix: risk factors for disease [Abstract]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 17 to 20, 1993. Washington, DC: American Society for Microbiology, 1993:1388.
13. Kaiser AB, Hennekens CH, Saslaw MS, Hayes PS, Bennett JV. Sero-epidemiology and chemoprophylaxis of disease due to sulphonamide resistant Neisseria meningitidis in a civilian population. J Infect Dis 1974;130:217-24.
14. Imrey PB, Jackson LA, Ludwinski PH, et al. An outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol 1996;143:624-30.
15. Centers for Disease Control and Prevention. Serogroup B meningococcal disease: Oregon, 1994. MMWR 1995;44: 121-4.
16. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984;120:825-33.
17. Walter S. Calculation of attributable risks from epidemiological data. Int J Epidemiol 1978;7:175-82.
18. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122: 904-14.
19. Overpeck MD, Moss AJ. Children's exposure to environmental cigarette smoke before and after birth: health of our nation's children, United States, 1988. Adv Data 1991;202:1-12.
20. 1993 Behavioral Risk Factor Surveillance System Report. National Center for Chronic Disease Prevention and Health Promotion. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
21. Caugant DA, Hoiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994;32:323-30.
22. Stuart JM, Cartwright KAV, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet 1989;2:723-5.
23. Blackwell CC, Tzanakaki G, Kremastinou J, et al. Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect 1992;108:441-8.
24. Cook DG, Whincup PH, Jarvis MJ, Strachan DP, Papacosta O, Bryant A. Passive exposure to tobacco smoke in children aged 5-7 years: individual, family, and community factors. Br Med J 1994;308:384-9.
25. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994;49:825-34.
26. Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med 1967;276:421-7.
27. Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest 1983;83:23-7.
28. Merrill WW, Goodenberger D, Strober W, et al. Free secretory component of IgA in the lung lavage of normal smokers and non-smokers [Abstract]. Am Rev Respir Dis 1979;119:76.
29. DiFranza JR, Lew RA. Morbidity and mortality in children associated with the use of tobacco products by other people. Pediatrics 1996;97:560-8.
30. Abramson JS, Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J 1994;13:643-52.
31. Raza MW, Ogilvie MM, Blackwell CC, Stewart J, Elton RA, Weir DM. Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to a human epithelial cell line (Hep-2). Epidemiol Infect 1993;110:339-47.
32. Silva J Jr, Nealon TJ, Reinarz JA. A selective phagocyte defect for killing of N. meningitidis during adenoviral infections [Abstract]. Clin Res 1972;20:55.
33. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 1995;123:937-40.
34. Rosenstein N, Levine O, Taylor J, et al. Persistent serogroup C meningococcal disease outbreak in a vaccinated population, Gregg County, Texas [Abstract]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 16 to 20, 1996. Washington, DC: American Society for Microbiology, 1996: 158.